Transplantation of “iPS cells” to three patients with Parkinson's disease is progressing smoothly

“IPS cell” transplantation to 3 patients with Parkinson's disease progressing smoothly February 5 at 5:19

k10012272871_202002050440_202002050515.mp4

A group at Kyoto University is conducting a clinical trial to transplant cells created from iPS cells into the brain of a patient with Parkinson's disease, an intractable disease that gradually becomes immobile. There were no noticeable side effects, and the course was well underway.

Parkinson's disease is an incurable disease in which the nerve cells in the brain that make up dopamine, a neurotransmitter, are lost, causing limbs to shake or the body to move.

A group of professors Ryosuke Takahashi of Kyoto University Hospital and Jun Takahashi of Kyoto University's iPS Cell Research Institute has transplanted cells produced from human iPS cells into the brain of patients with Parkinson's disease to restore their function. In October, the world's first transplant surgery was performed.

There were no problems with this patient's course, and it was renewed that the group had transplanted two more patients last year.

According to the group, all three patients did not have any side effects such as cancer of the transplanted cells, and the progress has been smooth.

The group plans to transplant four more patients next year and aims to receive state approval to make it a common treatment covered by insurance.

According to Professor Ryosuke Takahashi, "We are proceeding smoothly according to the plan. We will continue to carefully and carefully evaluate the efficacy and safety."